The disruption of these six distal CREs each significantly reduced FOXA1 mRNA levels, similar to what has been demonstrated for ESR1 in luminal breast cancer32, MLH1 in Lynch syndrome53, MYC in lung adenocarcinoma and endometrial cancer54 and AR in mCRPC55,56. The gene discussed is MYC; the disease is lung adenocarcinoma.